Stephanie Lee
National University of Singapore · Fred Hutch/University of Washington Cancer Consortium · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
9 more share only the name and are not shown
Trial papers
5455
PubMed author-name match
Trials
Studies that name Stephanie Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:32 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06202677 · Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder SymptomsNational University of Singapore · unknown · Obsessive-Compulsive Disorder · principal investigator
- Ph2NCT05996627 · Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host DiseaseFred Hutchinson Cancer Center · recruiting · Chronic Graft Versus Host Disease · principal investigator
- Ph2NCT04198922 · Acalabrutinib for the Treatment of Chronic Graft Versus Host DiseaseFred Hutchinson Cancer Center · active not recruiting · Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- N/ANCT04188912 · Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH StudyFred Hutchinson Cancer Center · completed · Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph1/Ph2NCT04111497 · Glasdegib for Chronic Graft-Versus-Host DiseaseFred Hutchinson Cancer Center · terminated · Chronic Graft Versus Host Disease, Fasciitis · principal investigator
- N/ANCT03525106 · Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their CaregiversFred Hutchinson Cancer Center · completed · Hematopoietic Cell Transplantation Recipient · principal investigator
- Ph2NCT03483675 · Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host DiseaseFred Hutchinson Cancer Center · completed · Chronic Graft Versus Host Disease · principal investigator
- Ph2NCT02513498 · Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host DiseaseFred Hutchinson Cancer Center · completed · Chronic Graft Versus Host Disease · principal investigator
- Ph2NCT02491359 · Carfilzomib in Treating Patients With Chronic Graft-Versus-Host DiseaseFred Hutchinson Cancer Center · completed · Chronic Graft Versus Host Disease · principal investigator
- Ph2NCT02174263 · Tocilizumab for Chronic Graft-versus-Host Disease TreatmentFred Hutchinson Cancer Center · withdrawn · Graft Versus Host Disease · principal investigator
- N/ANCT01758484 · Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell TransplantFred Hutchinson Cancer Center · completed · Hematopoietic/Lymphoid Cancer · principal investigator
- Ph2NCT01616056 · Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host DiseaseFred Hutchinson Cancer Center · completed · Graft Versus Host Disease, Ophthalmologic Complications · principal investigator
- Ph2NCT01309997 · Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host DiseaseLee, Stephanie · completed · Graft Versus Host Disease, Systemic Scleroderma · principal investigator
- Ph2NCT01307462 · Targeted Therapy of Bronchiolitis Obliterans SyndromeStephanie Lee · completed · Bronchiolitis Obliterans · principal investigator
- N/ANCT01206309 · Immune Mediated Disorders After Allogeneic Hematopoietic Cell TransplantationFred Hutchinson Cancer Center · completed · Graft vs Host Disease, Cutaneous Sclerosis, Bronchiolitis Obliterans · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- BMT CTN Core - Fred Hutchinson Cancer CenterUG1HL069246 · NHLBI · FRED HUTCHINSON CANCER CENTER · fiscal years 2022 to 2026 · $264,000 awarded in 2026Same name and institution; not confirmed by an ID
- Core D: Long-Term Follow-UpP01CA018029 · NCI · FRED HUTCHINSON CANCER CENTER · fiscal years 2018 to 2026 · $418,106 awarded in 2026Same name and institution; not confirmed by an ID
- Improving Outcomes Assessment in Chronic Graft versus Host DiseaseR01CA118953 · NCI · FRED HUTCHINSON CANCER CENTER · fiscal years 2011 to 2025 · $535,000 awarded in 2025Same name and institution; not confirmed by an ID
- Ustekinumab for Graft versus Host Disease Prevention (IND 144540)R01FD006836 · FDA · FRED HUTCHINSON CANCER CENTER · fiscal years 2020 to 2025 · $876,984 awarded in 2025Same name and institution; not confirmed by an ID
- Biologic correlatives of chronic GVHD onsetU01CA236229 · NCI · FRED HUTCHINSON CANCER CENTER · fiscal years 2019 to 2023 · $839,470 awarded in 2023Grant number is on one of their registry trials
- Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)U54CA163438 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2011 to 2014 · $300,000 awarded in 2014Grant number is on one of their registry trials
- Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)U54AI083028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2009 to 2010 · $1,237,500 awarded in 2010Same name and institution; not confirmed by an ID
- Improving Outcomes Assessment in Chronic GVHDU01CA118953 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2007 to 2010 · $59,000 awarded in 2010Same name and institution; not confirmed by an ID
- Enhancing Doctor-Patient CommunicationR01CA098486 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2003 to 2006 · $475,556 awarded in 2006Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA015704 · NCI · FRED HUTCHINSON CANCER CENTER · PI WENDY LAW · fiscal years 2018 to 2026Named on NCT03525106, NCT03483675, NCT02513498, NCT02491359, NCT02174263, NCT01758484, NCT01616056, NCT01309997
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:32 UTC. The ranking covers the 200 most relevant of 5455 PubMed records, and a shared surname and initials can bring in a namesake. All 5455 on PubMed
- 320 citationsRCR 34.5
- Colchicine in Acute Myocardial Infarction.N Engl J Med · 2025292 citationsRCR 76.5
- Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.N Engl J Med · 2025222 citationsRCR 85.6
- Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.N Engl J Med · 2025175 citationsRCR 63.3
- 169 citationsRCR 16.1
- 145 citationsRCR 14.7
- Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.N Engl J Med · 2024139 citationsRCR 18.4
- Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.N Engl J Med · 2025135 citationsRCR 26.4
- 125 citationsRCR 16.8
- 114 citationsRCR 23.0